
April 1 (Reuters) - Maia Biotechnology Inc MAIA.A:
MAIA BIOTECHNOLOGY- PHASE 2 TRIAL THIO-101 EXPANSION UNDERWAY; POTENTIAL FILING IN 2026 FOR ACCELERATED APPROVAL
MAIA BIOTECHNOLOGY- PHASE 3 THIO-104 SET TO BEGIN IN MID-2025; POTENTIAL FILING IN 2026 FOR EARLY FULL APPROVAL